Vanguard Group
STRM

Vanguard Group’s Streamline Health Solutions STRM Stock Holding History

Vanguard Group’s Portfolio STRM Stock Details STRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-112,558
Closed -$582K – 4421
2025
Q2 		$582K Hold
112,558
– – ﹤0.01% 3886
2025
Q1 		$315K Buy
112,558
+1,252
+1% +$4.48K ﹤0.01% 3987
2024
Q4 		$419K Sell
111,306
-3
-0% -$8 ﹤0.01% 3984
2024
Q3 		$384K Hold
111,309
– – ﹤0.01% 4035
2024
Q2 		$769K Sell
111,309
-456
-0.4% -$2.71K ﹤0.01% 3879
2024
Q1 		$805K Sell
111,765
-27
-0% -$187 ﹤0.01% 3882
2023
Q4 		$713K Sell
111,792
-762
-0.7% -$4.85K ﹤0.01% 3925
2023
Q3 		$1.63M Buy
112,554
+1,747
+2% +$30.3K ﹤0.01% 3654
2023
Q2 		$2.11M Buy
110,807
+1,409
+1% +$33.9K ﹤0.01% 3636
2023
Q1 		$2.95M Buy
109,398
+7,436
+7% +$211K ﹤0.01% 3534
2022
Q4 		$2.42M Sell
101,962
-2,361
-2% -$57.5K ﹤0.01% 3597
2022
Q3 		$1.86M Buy
104,323
+4,245
+4% +$95.3K ﹤0.01% 3777
2022
Q2 		$1.91M Buy
100,078
+121
+0.1% +$2.43K ﹤0.01% 3826
2022
Q1 		$2.4M Buy
99,957
+23,813
+31% +$510K ﹤0.01% 3890
2021
Q4 		$1.7M Buy
76,144
+132
+0.2% +$3.16K ﹤0.01% 4100
2021
Q3 		$2M Buy
76,012
+189
+0.2% +$4.67K ﹤0.01% 4052
2021
Q2 		$2.01M Buy
75,823
+7,508
+11% +$223K ﹤0.01% 3965
2021
Q1 		$2.1M Buy
68,315
+50,330
+280% +$1.44M ﹤0.01% 3851
2020
Q4 		$421K Hold
17,985
– – ﹤0.01% 3986
2020
Q3 		$421K Sell
17,985
-693
-4% -$14.5K ﹤0.01% 3841
2020
Q2 		$372K Hold
18,678
– – ﹤0.01% 3835
2020
Q1 		$239K Hold
18,678
– – ﹤0.01% 3833
2019
Q4 		$389K Hold
18,678
– – ﹤0.01% 3841
2019
Q3 		$308K Buy
18,678
+6,878
+58% +$143K ﹤0.01% 3896
2019
Q2 		$267K Buy
11,800
+4,103
+53% +$79K ﹤0.01% 3927
2019
Q1 		$121K Buy
7,697
+14
+0.2% +$234 ﹤0.01% 3994
2018
Q4 		$88K Sell
7,683
-11,658
-60% -$158K ﹤0.01% 4010
2018
Q3 		$342K Buy
19,341
+613
+3% +$11.7K ﹤0.01% 3914
2018
Q2 		$413K Sell
18,728
-423
-2% -$9.65K ﹤0.01% 3854
2018
Q1 		$529K Buy
19,151
+1,510
+9% +$39.1K ﹤0.01% 3776
2017
Q4 		$447K Buy
17,641
+2,287
+15% +$52.5K ﹤0.01% 3775
2017
Q3 		$339K Buy
15,354
+4,165
+37% +$75.1K ﹤0.01% 3818
2017
Q2 		$179K Sell
11,189
-2,922
-21% -$53.5K ﹤0.01% 3919
2017
Q1 		$216K Hold
14,111
– – ﹤0.01% 3892
2016
Q4 		$262K Sell
14,111
-1,264
-8% -$31.7K ﹤0.01% 3846
2016
Q3 		$425K Sell
15,375
-291
-2% -$6.54K ﹤0.01% 3787
2016
Q2 		$282K Hold
15,666
– – ﹤0.01% 3891
2016
Q1 		$331K Buy
15,666
+213
+1% +$4.8K ﹤0.01% 3866
2015
Q4 		$327K Hold
15,453
– – ﹤0.01% 3919
2015
Q3 		$531K Buy
15,453
+27
+0.2% +$1.09K ﹤0.01% 3832
2015
Q2 		$648K Buy
15,426
+1,260
+9% +$47.6K ﹤0.01% 3792
2015
Q1 		$759K Buy
14,166
+748
+6% +$45.1K ﹤0.01% 3702
2014
Q4 		$872K Buy
13,418
+783
+6% +$46.3K ﹤0.01% 3569
2014
Q3 		$877K Buy
12,635
+131
+1% +$9.18K ﹤0.01% 3550
2014
Q2 		$900K Hold
12,504
– – ﹤0.01% 3515
2014
Q1 		$943K Buy
12,504
+823
+7% +$76.5K ﹤0.01% 3475
2013
Q4 		$1.22M Buy
11,681
+7,164
+159% +$787K ﹤0.01% 3358
2013
Q3 		$515K Buy
4,517
+7
+0.2% +$765 ﹤0.01% 3544
2013
Q2 		$444K Buy
+4,510
New +$442K ﹤0.01% 3508

Other funds holding STRM

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Vanguard Group's STRM Position: Q3 2025 in Review

Vanguard Group sold out of Streamline Health Solutions (STRM) in Q3 2025, closing a stake of 112,558 shares — an estimated $582K sold.

Vanguard Group first reported a position in STRM in Q2 2013 and held it in 49 quarters. The position peaked at $2.95M in Q1 2023. 1 fund tracked by Wall St. Rank holds STRM as of Q3 2025.

  • Vanguard Group reported no remaining Streamline Health Solutions position as of Q3 2025 after selling out during the quarter.
  • Vanguard Group sold 112,558 Streamline Health Solutions shares in Q3 2025, an estimated $582K.
  • Vanguard Group first reported a position in Streamline Health Solutions in Q2 2013 and held it in 49 quarters.
  • Vanguard Group's Streamline Health Solutions position peaked at $2.95M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Streamline Health Solutions as of Q3 2025.

Based on Vanguard Group's 13F filing for Q3 2025, filed 7 Nov 2025.